Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.25259/IJDVL_99_2024 | DOI Listing |
Publication Analysis
Top Keywords
mesotherapy bicalutamide
4
bicalutamide female
4
female pattern
4
pattern hair
4
hair loss
4
mesotherapy
1
female
1
pattern
1
hair
1
loss
1
Similar Publications
Mesotherapy with bicalutamide for female pattern hair loss.
Indian J Dermatol Venereol Leprol
September 2024
Department of Dermatology, Rio de Janeiro State University (UERJ), R. São Francisco Xavier, Maracanã, Rio de Janeiro, Brazil.
Mesotherapy with Bicalutamide: A New Treatment for Androgenetic Alopecia.
Int J Trichology
April 2023
Trichology Unit, Ricart Medical Institute, Madrid and Valencia, Spain.
Bicalutamide is a selective androgen receptor antagonist. To date, it has been used orally with good efficacy results, but not in mesotherapy. In our center, we assessed whether patients undergoing bicalutamide mesotherapy showed positive responses and tolerated the local administration of bicalutamide.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!